Literature DB >> 9766827

Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?

C Robrechts1, R De Vos, M Van den Heuvel, E Van Cutsem, B Van Damme, V Desmet, T Roskams.   

Abstract

A 57-year-old female patient presented with painless obstructive jaundice and mild mesogastric pain; she was in good general condition on admission. Abdominal ultrasonography revealed diffuse tumoral invasion of the liver, suggesting diffuse metastases. A liver biopsy showed a tumour with a trabecular growth pattern, composed of uniform relatively small cells, very suggestive of an endocrine carcinoma. Additional immunohistochemical stains, however, did not show any endocrine differentiation, but showed positivity for both hepatocyte-type cytokeratins (cytokeratin 8 and 18) and bile duct-type cytokeratins (cytokeratin 7 and 19). In addition, parathyroid hormone-related peptide, shown to be a good marker for cholangiocarcinoma, was immunoreactive. Electron microscopy revealed tumour cells with an intermediate phenotype: the cells clearly showed hepatocyte features on one hand and bile duct cell features on the other hand. Nine days after admission, the patient died due to liver failure and hepatic encephalopathy. Autopsy excluded another primary tumour site. Overall, this tumour was a primary liver tumour with an intermediate phenotype and with a very rapid clinical course. The intermediate (between hepatocyte and bile duct cell) phenotype suggests an immature progenitor cell origin, which is concordant with a rapid clinical course. This type of tumour has not been described previously and provides additional evidence for the existence of progenitor cells in human liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766827     DOI: 10.1111/j.1600-0676.1998.tb00168.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  15 in total

Review 1.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

Review 2.  Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.

Authors:  Marco Marzioni; Giammarco Fava; Antonio Benedetti
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Prospero-related homeobox 1 (Prox1) is a stable hepatocyte marker during liver development, injury and regeneration, and is absent from "oval cells".

Authors:  Jozsef Dudas; Abderrahim Elmaouhoub; Tümen Mansuroglu; Danko Batusic; Kyrylo Tron; Bernhard Saile; Maria Papoutsi; Tomas Pieler; Joerg Wilting; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2006-06-13       Impact factor: 4.304

4.  Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Young-In Yoon; Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Jong-Woo Lee; Seung-Mo Hong; Eun Sil Yu; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-12-01       Impact factor: 3.452

5.  The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.

Authors:  Kwang-Pyo Lee; Joo-Hyeon Lee; Tae-Shin Kim; Tack-Hoon Kim; Hee-Dong Park; Jin-Seok Byun; Min-Chul Kim; Won-Il Jeong; Diego F Calvisi; Jin-Man Kim; Dae-Sik Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

6.  A case of cholangiolocellular carcinoma asynchronously developing 3 years after the resection of hepatocellular carcinoma.

Authors:  Masaya Iwamuro; Hirofumi Kawamoto; Tsuneyoshi Ogawa; Takehiro Tanaka; Takahito Yagi; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2009-02-11

Review 7.  Hepatic progenitor cells in human liver tumor development.

Authors:  Louis Libbrecht
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Hepatocellular carcinoma with characteristic mucin production: a case report.

Authors:  Kyung Hwa Lee; Young Bog Kim; Sung Bum Cho; Min Cheol Lee; Chang Soo Park; Jae Hyuk Lee
Journal:  Cases J       Date:  2009-08-25

9.  High expression of cancer stem cell markers in cholangiolocellular carcinoma.

Authors:  Shuichi Iwahashi; Tohru Utsunomiya; Mitsuo Shimada; Yu Saito; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Yoshimi Bando
Journal:  Surg Today       Date:  2012-11-29       Impact factor: 2.549

10.  Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches.

Authors:  Sudin Bhattacharya; Lisl K M Shoda; Qiang Zhang; Courtney G Woods; Brett A Howell; Scott Q Siler; Jeffrey L Woodhead; Yuching Yang; Patrick McMullen; Paul B Watkins; Melvin E Andersen
Journal:  Front Physiol       Date:  2012-12-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.